Results 91 to 100 of about 923,769 (294)

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Principles of assessment and management approaches to innovation potential of coal industry enterprises

open access: yesЗаписки Горного института, 2017
This paper examines problems related to forming a complex of indicators to assess innovation potential of an industrial enterprise, on the example of coal industry enterprises, and an integral indicator of innovation potential, used for comparative ...
A. V. Kozlov, A. B. Teslya, Sya Chzhan
doaj   +1 more source

The Lisbon Strategy [PDF]

open access: yes
The Lisbon Strategy Targets are presented and assessed as accordingly to the domains of the structural indicators, the common indicators created to measure the progress towards reaching these objectives: Economic performance; Employment; Research ...
Ivan Ungureanu, Clementina   +1 more
core  

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

EVOLUTIONANALYSIS OF ECO-INNOVATION INROMANIA IN THE CONTEXT OF SUSTAINABILITY [PDF]

open access: yesAnalele Universităţii Constantin Brâncuşi din Târgu Jiu : Seria Economie, 2015
In the current context, sustainability is a necessity of global development crisis. Its manifestations comprised in time the eco-innovation. In the last decade eco-innovation, it has faced significant developments, both internationally and nationally.
GOGONEA RODICA-MANUELA
doaj  

Organizational Competencies and Innovation Performances: The Case of Large Firms in Belgium [PDF]

open access: yes
The objective of this paper is to assess whether large firms' organizational competencies affect their innovation performances. About 40 organizational sub-competencies are defined and measured through an original survey questionnaire answered by 148 ...
Peeters, Carine   +1 more
core  

The multiple facets of regional innovation [PDF]

open access: yes, 2014
Measuring innovation activities involves critical decisions in selecting appropriate indicators and levels of observation. The present article contributes to the literature on this subject by addressing innovation measurement on the regional level.
Hauser, Christoph   +3 more
core  

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

Innovation and business performance - a provisional multi-regional analysis [PDF]

open access: yes
Although much attention has focussed on the determinants of firms' innovation performance, the relationship between innovation and business performance is less well defined.
Hewitt-Dundas, Nola   +4 more
core  

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

open access: yesMolecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy